Literature DB >> 22825800

The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation.

Stephen Senn1, Nick Holford, Hans Hockey.   

Abstract

A common but not necessarily logical requirement in drug development is that a 'limit of quantitation' be set for chemical assays and that observations that fall below the limit should not be treated as real data but should be labelled as below the limit and set aside for special treatment. We examine five of seven approaches to analysing such data considered by Beal in 2001, concentrating in particular on two: one that treats the data as a truncated sample and another that treats them as a censored sample. In fact, using a pattern-mixture framework, one can show that the former consists of using the conditional distribution of the 'acceptable values' and the latter adds the information from the marginal mixing distribution. We illustrate these approaches with a real example, concentrating in particular on the two likelihood-based methods, provide various formulae that may be used to compare these and other approaches, check these formulae using simulations and make some recommendations as to which approach one should use.
Copyright © 2012 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2012        PMID: 22825800     DOI: 10.1002/sim.5515

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

1.  An Evaluation of Statistical Methods for Analyzing Follow-Up Gaussian Laboratory Data with a Lower Quantification Limit.

Authors:  John M Karon; Ryan E Wiegand; Janneke H van de Wijgert; Peter H Kilmarx
Journal:  J Biopharm Stat       Date:  2015       Impact factor: 1.051

2.  Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR.

Authors:  Louise Marquart; Mark Baker; Peter O'Rourke; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2015-05-11       Impact factor: 5.191

Review 3.  How to deal with non-detectable and outlying values in biomarker research: Best practices and recommendations for univariate imputation approaches.

Authors:  Judith Herbers; Robert Miller; Andreas Walther; Lena Schindler; Kornelius Schmidt; Wei Gao; Florian Rupprecht
Journal:  Compr Psychoneuroendocrinol       Date:  2021-03-29

4.  Estimating limits for natural human embryo mortality.

Authors:  Gavin E Jarvis
Journal:  F1000Res       Date:  2016-08-26

5.  Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple Sclerosis.

Authors:  Xiao Hu; Yaming Hang; Yue Cui; Jie Zhang; Shifang Liu; Ali Seddighzadeh; Aaron Deykin; Ivan Nestorov
Journal:  J Clin Pharmacol       Date:  2017-04-10       Impact factor: 3.126

Review 6.  Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature.

Authors:  Sonia Khier; Laura Lohan
Journal:  Future Sci OA       Date:  2018-02-23

7.  Visually guided preprocessing of bioanalytical laboratory data using an interactive R notebook (pguIMP).

Authors:  Sebastian Malkusch; Lisa Hahnefeld; Robert Gurke; Jörn Lötsch
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-10-01

8.  Truncated lubricin glycans in osteoarthritis stimulate the synoviocyte secretion of VEGFA, IL-8, and MIP-1α: Interplay between O-linked glycosylation and inflammatory cytokines.

Authors:  Shan Huang; Kristina A Thomsson; Chunsheng Jin; Henrik Ryberg; Nabangshu Das; André Struglics; Ola Rolfson; Lena I Björkman; Thomas Eisler; Tannin A Schmidt; Gregory D Jay; Roman Krawetz; Niclas G Karlsson
Journal:  Front Mol Biosci       Date:  2022-09-21

9.  Urinary Elimination of Ecdysterone and Its Metabolites Following a Single-Dose Administration in Humans.

Authors:  Gabriella Ambrosio; Tasha Yuliandra; Bernhard Wuest; Monica Mazzarino; Xavier de la Torre; Francesco Botrè; Patrick Diel; Eduard Isenmann; Maria Kristina Parr
Journal:  Metabolites       Date:  2021-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.